FEATURES

Lecture: Changing the trajectory of heart failure - To help your patients endure

12 Nov 2020

Opening & discussion

 

Heart failure - Current status in Hong Kong

 

Changing the course of heart failure

 

Hospitalisation and mortality in patients with heart failure treated with sacubitril/valsartan vs. enalapril - What does the real-world evidence show us?

 

This is an educational material to HCPs sponsored by Novartis Pharmaceuticals (HK) Ltd, for the purpose of continuing medical education only.